prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1619
2018
-
T lymfocyty s chimerickým receptorem (CAR): revoluce v imunoterapii nádorů
Year: 2018, type:
-
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database
Annals of hematology, year: 2018, volume: 97, edition: 4, DOI
-
The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice
Journal of cancer research and clinical oncology, year: 2018, volume: 144, edition: 7, DOI
-
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients
Archives of Medical Science, year: 2018, volume: 14, edition: 6, DOI
-
Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling
Year: 2018, type: Conference abstract
-
Ultrasensitive detection of TKI resistant mutations using Illumina NGS in chronic myeloid leukemia patients.
Year: 2018, type: Conference abstract
-
Ultra-sensitive detection of tyrosine kinase inhibitor resistant mutations in chronic myeloid leukemia patients using Miseq Illumina next generation sequencing platform
Year: 2018, type: Conference abstract
-
Ultrasenzitivní detekce mutací způsobujících rezistenci na tyrozinkinázové inhibitory s použitím Illumina NGS platformy u pacientů s chronickou myeloidní leukémií
Year: 2018, type: Conference abstract
-
Unexpected role of Aurora kinase inhibitors in CD20 expression
Year: 2018, type: Conference abstract
-
Uvolnění buněk chronické lymfocytární leukemie z lymfatického systému do periferie po aplikaci rituximabu
Year: 2018, type: Conference abstract